Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

N-NITROSODIMETHYLAMINE

Related Products

Hot Products

Name

N-NITROSODIMETHYLAMINE

EINECS 200-549-8
CAS No. 62-75-9 Density 1.01g/mL(lit.)
PSA 32.67000 LogP 0.22940
Solubility soluble Melting Point 50 C
Formula C2H6 N2 O Boiling Point 151 - 154 C
Molecular Weight 90.0818 Flash Point 61 C
Transport Information OTH Appearance yellow oily liquid
Safety Risk Codes R45; R25; R26; R48/25; R51/53; R39/23/24/25; R23/24/25; R11
Molecular Structure Molecular Structure of 62-75-9 (N-Methyl-N-nitrosomethanamine) Hazard Symbols UN NO.
Synonyms

Dimethylamine,N-nitroso- (8CI); DMN; DMNA; Dimethylnitrosamine;N-Methyl-N-nitrosomethanamine; N-Nitroso-N,N-dimethylamine; N-Nitrosodimethylamine;NDMA; NSC 23226

Article Data 97

N-NITROSODIMETHYLAMINE Chemical Properties

Product Name: n-Nitrosodimethylamine (62-75-9)


Molecular Formula: C2H6N2O
Molecular Weight: 74.08g/mol
Mol File: 62-75-9.mol
Einecs: 200-549-8
Appearance: yellow oily liquid
Melting Point: 50°C
Boiling point: 153 °C 774 mm Hg(lit.)
Flash Point: 36.1 °C
Density: 1.01 g/mL(lit.)
Vapor pressure: 5 mm Hg ( 20 °C)
Refractive index: n20/D 1.437(lit.)
Water Solubility: soluble
Stability: Stability Stable, but light-sensitive. Combustible. Incompatible with strong oxidizing agents, strong bases, strong reducing agents.
Product Categories: Nitrosamine;NA - NIEPA ; TO-7: N-Nitrosodimethylamine By Capillary GC-MS ; AliphaticsVolatiles/ Semivolatiles ; Alpha Sort ; Amines ; Chemical Class ; EPA TO Methods ; N ; N-OAlphabetic
Synonyms of  n-Nitrosodimethylamine (62-75-9): (ch3)2nno ; 1,1-dimethyl-2-oxohydrazine ; dimethylamine, n-nitroso ; dimethylnitrosamin ; dimethylnitrosoamine ; dimethyl-nitroso-amine ; dmn ; dmna .

N-NITROSODIMETHYLAMINE Uses

Organic synthesis intermediates. Used in rocket fuel, antioxidants and other manufacturing.

N-NITROSODIMETHYLAMINE Production

Be 245g dimethylamine hydrochloride and mixing hydrochloric acid heated to 70-75 ℃, adding 235g of sodium nitrite in 150ml water slurry liquid, while adding hydrochloric acid to make exactly acidic reactant. Canadian Bi, heating 2h, and then distilled to nearly dry, add water and then evaporated, the distillate combined with 300g of saturated potassium carbonate to make, take the upper vacuum fractionation, may close 200gN-nitroso-dimethylamine, the yield of nearly 90 %.

N-NITROSODIMETHYLAMINE Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LCLo inhalation 16ppm/4H (16ppm) BEHAVIORAL: FOOD INTAKE (ANIMAL)

GASTROINTESTINAL: NAUSEA OR VOMITING
AMA Archives of Industrial Health. Vol. 12, Pg. 617, 1955.
dog LDLo oral 20mg/kg (20mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

GASTROINTESTINAL: NAUSEA OR VOMITING

BLOOD: HEMORRHAGE
British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
guinea pig LD50 intraperitoneal 13700ug/kg (13.7mg/kg)   Carcinogenesis Vol. 5, Pg. 533, 1984.
guinea pig LDLo oral 25mg/kg (25mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

KIDNEY, URETER, AND BLADDER: CHANGES PRIMARILY IN GLOMERULI

BLOOD: THROMBOCYTOPENIA
"Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 183, 1999.
guinea pig LDLo unreported 25mg/kg (25mg/kg) BLOOD: HEMORRHAGE British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
hamster LD50 oral 28mg/kg (28mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH

LIVER: FATTY LIVER DEGERATION

LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE"
Journal of the National Cancer Institute. Vol. 33, Pg. 341, 1964.
hamster LD50 subcutaneous 17700ug/kg (17.7mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

LIVER: OTHER CHANGES

BLOOD: OTHER CHANGES
British Journal of Cancer. Vol. 33, Pg. 411, 1976.
hamster LDLo intraperitoneal 30mg/kg (30mg/kg)   Carcinogenesis Vol. 1, Pg. 91, 1980.
mammal (species unspecified) LD50 subcutaneous 10mg/kg (10mg/kg)   Acta Veterinaria Scandinavica. Vol. 22, Pg. 501, 1981.
mammal (species unspecified) LD50 subcutaneous 10mg/kg (10mg/kg)   Acta Veterinaria Scandinavica. Vol. 22, Pg. 501, 1981.
mammal (species unspecified) LD50 subcutaneous 10mg/kg (10mg/kg) LIVER: OTHER CHANGES Acta Veterinaria Scandinavica. Vol. 22, Pg. 501, 1981.
mouse LC50 inhalation 57ppm/4H (57ppm) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: HEMORRHAGE
AMA Archives of Industrial Health. Vol. 12, Pg. 617, 1955.
mouse LD50 intraperitoneal 19mg/kg (19mg/kg)   Experientia. Vol. 32, Pg. 495, 1976.
mouse LDLo unreported 20mg/kg (20mg/kg) LIVER: OTHER CHANGES British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
rabbit LDLo oral 10mg/kg (10mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

KIDNEY, URETER, AND BLADDER: CHANGES PRIMARILY IN GLOMERULI

BLOOD: THROMBOCYTOPENIA
"Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 183, 1999.
rabbit LDLo unreported 10mg/kg (10mg/kg) LIVER: OTHER CHANGES British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
rat LC50 inhalation 78ppm/4H (78ppm) SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: HEMORRHAGE
AMA Archives of Industrial Health. Vol. 12, Pg. 617, 1955.
rat LD50 intraperitoneal 26500ug/kg (26.5mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
rat LD50 oral 37mg/kg (37mg/kg)   Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 50(8), Pg. 81, 1985.
rat LD50 subcutaneous 15mg/kg (15mg/kg) LIVER: LIVER FUNCTION TESTS IMPAIRED

KIDNEY, URETER, AND BLADDER: CHANGES PRIMARILY IN GLOMERULI

BLOOD: THROMBOCYTOPENIA
"Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 183, 1999.
rat LD50 unreported 36mg/kg (36mg/kg)   Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 45(8), Pg. 11, 1980.
rat LDLo intravenous 40mg/kg (40mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

GASTROINTESTINAL: OTHER CHANGES

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
British Journal of Industrial Medicine. Vol. 11, Pg. 167, 1954.
women LDLo oral 20mg/kg/2.5Y (20mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE

GASTROINTESTINAL: NAUSEA OR VOMITING
Oncology. Vol. 37, Pg. 273, 1980.

N-NITROSODIMETHYLAMINE Consensus Reports

NTP 10th Report on Carcinogens. IARC Cancer Review: Group 2A IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 125.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 ,1972,p. 95.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 125.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Inadequate Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 ,1972,p. 95.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Reported in EPA TSCA Inventory. EPA Genetic Toxicology Program. Community Right-To-Know List. EPA Extremely Hazardous Substances List.

N-NITROSODIMETHYLAMINE Safety Profile

Confirmed carcinogen with experimental carcinogenic, neoplastigenic, tumorigenic, and teratogenic data. A transplacental carcinogen. Human poison by ingestion. Experimental poison by ingestion, inhalation, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by ingestion: ulceration or bleeding from small intestine, nausea or vomiting, and fever. Experimental reproductive effects. Human mutation data reported. Has caused fatal liver disease in humans. When heated to decomposition it emits toxic fumes of NOx. See also NITROSAMINES.
Analytical Methods: 
For occupational chemical analysis use OSHA: #27.
When heated to decomposition, n-Nitrosodimethylamine emits toxic fumes of nitrogen oxides. Avoid exposure to ultraviolet light.
Safety Information of  n-Nitrosodimethylamine (62-75-9):
Hazard Codes: T+,N,F
Risk Statements: 45-25-26-48/25-51/53-39/23/24/25-23/24/25-11 
11:  Highly Flammable 
23:  Toxic by inhalation 
24:  Toxic in contact with skin 
25:  Toxic if swallowed 
26:  Very Toxic by inhalation 
39:  Danger of very serious irreversible effects
45:  May cause cancer 
48:  Danger of serious damage to health by prolonged exposure 
51:  Toxic to aquatic organisms
53:  May cause long-term adverse effects in the aquatic environment
Safety Statements: 53-45-61-36/37
36:  Wear suitable protective clothing 
37:  Wear suitable gloves 
45:  In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
53:  Avoid exposure - obtain special instruction before use 
61:  Avoid release to the environment. Refer to special instructions safety data sheet 

N-NITROSODIMETHYLAMINE Standards and Recommendations

OSHA PEL: Cancer Suspect Agent
ACGIH TLV: Animal Carcinogen
DFG MAK: Animal Carcinogen, Suspected Human Carcinogen

N-NITROSODIMETHYLAMINE Analytical Methods

For occupational chemical analysis use OSHA: #27.

N-NITROSODIMETHYLAMINE Specification

 n-Nitrosodimethylamine (62-75-9) is a yellow oily liquid with a faint characteristic odor. It can reasonably be expected to be a carcinogen. Used as an antioxidant, as an additive for lubricants and as a softener of copolymers. An intermediate in 1,1-dimethylhydrazine production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 62-75-9